ZVRA Q4 2022 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$618M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-10.2% YoY

Gross Profit

$2M93.8% margin

Operating Income

-$9M-399.0% margin

Net Income

-$9M-389.0% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

-19.3%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$115M

Total Liabilities

$40M

Stockholders' Equity

$75M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-10.2%
Gross Profit	$2M	$3M	-13.8%
Operating Income	-$9M	-$3M	-225.6%
Net Income	-$9M	-$3M	-233.7%